# Black Diamond Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2025

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: 10-K
- Filed: 2026-03-16
- Accepted by EDGAR: Mar 16, 2026, 16:03 ET
- Period: 2025-12-31
- Accession: 0001701541-26-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000170154126000009/bdtx-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000170154126000009/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | $70.0m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Research and development | 12 months, 2025-01-01 to 2025-12-31 | $33.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | $12.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | $22.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | $0.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | $0.39 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2025-01-01 to 2025-12-31 | 57,562,746 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | $29.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2025-12-31 | $21.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $132.4m | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $143.0m | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $15.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-12-31 | $30.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2025-12-31 | $112.2m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000170154126000009/bdtx-20251231.htm

Filed Mar 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001701541-26-000009. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.